Gene

AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact

AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact

2 hours ago   |   Xconomy

AbbVie has terminated a research partnership with Editas Medicines, returning to the biotech rights to an experimental gene-editing treatment. It's the second genetic medicines...
Read more ...

Scientists use CRISPR to knock down gene messages early in development

3 hours ago   |   Phys

Since its discovery, scientists have been using the much-lauded gene editing tool CRISPR to alter the DNA of model organisms and uncover the functions of thousands of genes...
Read more ...

Integration of gene regulatory networks in understanding animal behavior

3 hours ago   |   Phys

For years, scientists have attributed animal behavior to the coordinated activities of neuronal cells and its circuits of neurons, known as the neuronal network. However...
Read more ...

Activation and enhancement of caerulomycin A biosynthesis in marine-derived Actinoalloteichus sp. AHMU CJ021 by combinatorial genome mining strategies

7 hours ago   |   Microbial Cell Factories

Activation of silent biosynthetic gene clusters in marine-derived actinomycete strains is a feasible strategy to discover bioactive natural products. Actinoalloteichus sp. AHMU...
Read more ...

SOAPMetaS: profiling large metagenome datasets efficiently on distributed clusters

7 hours ago   |   Oxford Journals

AbstractSummaryRapid increase of the data size in metagenome researches has raised the demand for new tools to process large datasets efficiently. In order to accelerate the...
Read more ...

Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production

9 hours ago   |   Wiley

Abstract Modified Vaccinia Ankara virus is a promising vector for vaccination against various challenging pathogens or the treatment of some types of cancers. Because this...
Read more ...

Scientists use CRISPR to knock down gene messages early in development

9 hours ago   |   ScienceDaily

Researchers have harnessed the technology to target gene messages involved in early vertebrate development.
Read more ...

Modification of transcriptional factor ACE3 enhances protein production in Trichoderma reesei in the absence of cellulase gene inducer

10 hours ago   |   Biotechnology for Biofuels

Trichoderma reesei is one of the best-known cellulolytic organisms, producing large quantities of a complete set of extracellular cellulases and hemicellulases for the...
Read more ...

De novo transcriptome of the whole-body of the gastropod mollusk Philomycus bilineatus, a pest with medical potential in China

11 hours ago   |   Springer

Abstract Philomycus bilineatus is a highly common gastropod mollusk pest in China and is also utilized to treat infectious diseases. However, no genomic resources are available...
Read more ...

Establishment and evaluation of a method for efficient screening of Clostridium butyricum

11 hours ago   |   Springer

Abstract At present, the traditional methods for the screening of Clostridium butyricum are not sufficiently selective and efficient. Therefore, it is necessary to establish a...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Biogen to Pay Denali $1B to Partner on Parkinson's Drug & Other Neuro Meds

Biogen to Pay Denali $1B to Partner on Parkinson's Drug & Other Neuro Meds

Denali Therapeutics has selected a brain-penetrating Parkinson's disease drug candidate to advance to late-stage testing and Biogen is paying $1 billion to kick off a... Read more ...

AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact

AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact

AbbVie has terminated a research partnership with Editas Medicines, returning to the biotech rights to an experimental gene-editing treatment. It's the second genetic medicines... Read more ...

FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy

FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy

The FDA on Friday approved a new spinal muscular atrophy drug that patients can take at home. Risdiplam is a liquid medicine intended for daily use that was developed by Roche... Read more ...

Five Question Friday: Jo Tang

Five Question Friday: Jo Tang

Welcome to Five Question Friday! This is the first blog post of a new monthly series, where we will introduce you to the employees of GreenLight. You'll get to know our team... Read more ...

Bio Roundup: A Telehealth Combo, FDA's BCMA OK, Biogen's Bet & More

Bio Roundup: A Telehealth Combo, FDA's BCMA OK, Biogen's Bet & More

The novel coronavirus has driven the pharmaceutical industry to upend its research priorities. Big Pharma companies are focusing on vaccine development and a slew of biotechs... Read more ...

Moderna, Pfizer Protocols May Make COVID Vaccines Hard to Compare

Moderna, Pfizer Protocols May Make COVID Vaccines Hard to Compare

It will be difficult to compare Moderna, Inc. and Pfizer Inc.'s coronavirus vaccines based on their Phase 3 study designs, some vaccines experts said. “Both trials appeared to... Read more ...

“Murder Hornet” Genome Rapidly Assembled by USDA as Part of Real-Time...

“Murder Hornet” Genome Rapidly Assembled by USDA as Part of Real-Time Invasive Species Response Initiative

With a nickname like “murder hornet,” it's no wonder the two-inch long Asian giant hornet has caused a stir amongst those terrified of insect invasions. Various species of... Read more ...

GlaxoSmithKline Multiple Myeloma Drug Earns FDA's First Anti-BCMA Nod

GlaxoSmithKline Multiple Myeloma Drug Earns FDA's First Anti-BCMA Nod

Patients with advanced multiple myeloma have a new treatment option with the FDA's approval of a GlaxoSmithKline drug that targets B-cell maturation antigen, a protein found on... Read more ...

G1 Vets Launch Arc Therapeutics to Take on New Cancer Target

G1 Vets Launch Arc Therapeutics to Take on New Cancer Target

Three early employees of G1 Therapeutics have launched a new oncology-focused company and raised $6 million to move a preclinical program licensed from their former employer... Read more ...

New Partnership Seeds Microbiome Research

New Partnership Seeds Microbiome Research

At the February workshop organized by the National Microbiome Data Collaborative, the MOU creating the Tri-institutional Partnership for Microbiome Research was formally... Read more ...